nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0166	0.022	CbGpPWpGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0159	0.0211	CbGpPWpGaD
Metixene—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0157	0.0209	CbGpPWpGaD
Metixene—CHRM4—nervous system—Gilles de la Tourette syndrome	0.0156	0.0919	CbGeAlD
Metixene—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.015	0.0885	CbGeAlD
Metixene—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0142	0.0188	CbGpPWpGaD
Metixene—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0137	0.0183	CbGpPWpGaD
Metixene—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0136	0.018	CbGpPWpGaD
Metixene—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0132	0.0175	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.013	0.0172	CbGpPWpGaD
Metixene—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0128	0.017	CbGpPWpGaD
Metixene—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0123	0.0163	CbGpPWpGaD
Metixene—CHRM5—nervous system—Gilles de la Tourette syndrome	0.0122	0.0718	CbGeAlD
Metixene—CHRM4—brain—Gilles de la Tourette syndrome	0.0119	0.0702	CbGeAlD
Metixene—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0119	0.0158	CbGpPWpGaD
Metixene—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.0117	0.0691	CbGeAlD
Metixene—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0116	0.0153	CbGpPWpGaD
Metixene—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0114	0.0151	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0112	0.0149	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0112	0.0148	CbGpPWpGaD
Metixene—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0111	0.0147	CbGpPWpGaD
Metixene—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0111	0.0147	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0111	0.0147	CbGpPWpGaD
Metixene—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0108	0.0143	CbGpPWpGaD
Metixene—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0107	0.0142	CbGpPWpGaD
Metixene—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.0105	0.0139	CbGpPWpGaD
Metixene—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0103	0.0137	CbGpPWpGaD
Metixene—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.01	0.0133	CbGpPWpGaD
Metixene—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00982	0.0578	CbGeAlD
Metixene—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00955	0.0127	CbGpPWpGaD
Metixene—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00952	0.0126	CbGpPWpGaD
Metixene—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00943	0.0125	CbGpPWpGaD
Metixene—CHRM5—brain—Gilles de la Tourette syndrome	0.00932	0.0549	CbGeAlD
Metixene—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00929	0.0123	CbGpPWpGaD
Metixene—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00927	0.0123	CbGpPWpGaD
Metixene—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00924	0.0123	CbGpPWpGaD
Metixene—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00915	0.0121	CbGpPWpGaD
Metixene—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00902	0.012	CbGpPWpGaD
Metixene—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00897	0.0119	CbGpPWpGaD
Metixene—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00864	0.0115	CbGpPWpGaD
Metixene—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00861	0.0114	CbGpPWpGaD
Metixene—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00859	0.0114	CbGpPWpGaD
Metixene—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00852	0.0113	CbGpPWpGaD
Metixene—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0084	0.0112	CbGpPWpGaD
Metixene—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00837	0.0493	CbGeAlD
Metixene—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00807	0.0475	CbGeAlD
Metixene—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00806	0.0475	CbGeAlD
Metixene—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00803	0.0107	CbGpPWpGaD
Metixene—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.008	0.0106	CbGpPWpGaD
Metixene—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00792	0.0105	CbGpPWpGaD
Metixene—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00779	0.0103	CbGpPWpGaD
Metixene—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00777	0.0457	CbGeAlD
Metixene—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00777	0.0103	CbGpPWpGaD
Metixene—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00769	0.0102	CbGpPWpGaD
Metixene—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00762	0.0449	CbGeAlD
Metixene—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00754	0.01	CbGpPWpGaD
Metixene—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00734	0.0432	CbGeAlD
Metixene—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00726	0.00964	CbGpPWpGaD
Metixene—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00724	0.00961	CbGpPWpGaD
Metixene—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00722	0.00959	CbGpPWpGaD
Metixene—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00717	0.00951	CbGpPWpGaD
Metixene—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.007	0.0093	CbGpPWpGaD
Metixene—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00682	0.0402	CbGeAlD
Metixene—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00657	0.0387	CbGeAlD
Metixene—CHRM2—brain—Gilles de la Tourette syndrome	0.0064	0.0377	CbGeAlD
Metixene—HTR2C—brain—Gilles de la Tourette syndrome	0.00617	0.0363	CbGeAlD
Metixene—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00605	0.00803	CbGpPWpGaD
Metixene—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00603	0.008	CbGpPWpGaD
Metixene—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00597	0.00793	CbGpPWpGaD
Metixene—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00589	0.00781	CbGpPWpGaD
Metixene—CHRM1—brain—Gilles de la Tourette syndrome	0.00582	0.0343	CbGeAlD
Metixene—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.00564	0.0733	CrCbGaD
Metixene—CHRM3—brain—Gilles de la Tourette syndrome	0.00521	0.0307	CbGeAlD
Metixene—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00508	0.00675	CbGpPWpGaD
Metixene—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00507	0.00673	CbGpPWpGaD
Metixene—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00502	0.00666	CbGpPWpGaD
Metixene—Mirtazapine—DRD4—Gilles de la Tourette syndrome	0.00456	0.0593	CrCbGaD
Metixene—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00423	0.00561	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00419	0.00556	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0041	0.00545	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00406	0.0054	CbGpPWpGaD
Metixene—Maprotiline—SLC6A3—Gilles de la Tourette syndrome	0.004	0.052	CrCbGaD
Metixene—Mirtazapine—DRD3—Gilles de la Tourette syndrome	0.00394	0.0511	CrCbGaD
Metixene—Mirtazapine—SLC6A3—Gilles de la Tourette syndrome	0.00366	0.0476	CrCbGaD
Metixene—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.0033	0.0429	CrCbGaD
Metixene—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.0032	0.0416	CrCbGaD
Metixene—Maprotiline—DRD2—Gilles de la Tourette syndrome	0.00298	0.0387	CrCbGaD
Metixene—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00294	0.00391	CbGpPWpGaD
Metixene—Mianserin—DRD3—Gilles de la Tourette syndrome	0.00289	0.0376	CrCbGaD
Metixene—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00286	0.0038	CbGpPWpGaD
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00273	0.00363	CbGpPWpGaD
Metixene—Mirtazapine—DRD2—Gilles de la Tourette syndrome	0.00272	0.0354	CrCbGaD
Metixene—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.00269	0.035	CrCbGaD
Metixene—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00268	0.00356	CbGpPWpGaD
Metixene—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00266	0.00354	CbGpPWpGaD
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00265	0.00352	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00265	0.00352	CbGpPWpGaD
Metixene—Cyproheptadine—DRD2—Gilles de la Tourette syndrome	0.00264	0.0343	CrCbGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00262	0.00347	CbGpPWpGaD
Metixene—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.0026	0.0338	CrCbGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00254	0.00337	CbGpPWpGaD
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00247	0.00328	CbGpPWpGaD
Metixene—Promazine—DRD4—Gilles de la Tourette syndrome	0.00239	0.0311	CrCbGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00237	0.00314	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00234	0.00311	CbGpPWpGaD
Metixene—Maprotiline—HTR2A—Gilles de la Tourette syndrome	0.0023	0.0299	CrCbGaD
Metixene—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.00229	0.0297	CrCbGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00227	0.00302	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00225	0.00299	CbGpPWpGaD
Metixene—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.00224	0.0291	CrCbGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00224	0.00298	CbGpPWpGaD
Metixene—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.00221	0.0288	CrCbGaD
Metixene—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00218	0.0029	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00218	0.00289	CbGpPWpGaD
Metixene—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00214	0.00285	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00213	0.00283	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00212	0.00281	CbGpPWpGaD
Metixene—Mirtazapine—HTR2A—Gilles de la Tourette syndrome	0.0021	0.0274	CrCbGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00207	0.00275	CbGpPWpGaD
Metixene—Cyproheptadine—HTR2A—Gilles de la Tourette syndrome	0.00204	0.0265	CrCbGaD
Metixene—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00203	0.0027	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00203	0.00269	CbGpPWpGaD
Metixene—Mianserin—DRD2—Gilles de la Tourette syndrome	0.002	0.026	CrCbGaD
Metixene—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00196	0.0026	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00193	0.00256	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00255	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0019	0.00253	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00184	0.00245	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00184	0.00244	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00183	0.00243	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00182	0.00241	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00179	0.00237	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00178	0.00237	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00178	0.00237	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00177	0.00236	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00177	0.00235	CbGpPWpGaD
Metixene—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.00177	0.023	CrCbGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00177	0.00234	CbGpPWpGaD
Metixene—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00175	0.00232	CbGpPWpGaD
Metixene—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00173	0.0023	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00173	0.0023	CbGpPWpGaD
Metixene—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.00172	0.0224	CrCbGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00172	0.00229	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00171	0.00227	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00167	0.00221	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00166	0.00221	CbGpPWpGaD
Metixene—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00166	0.0022	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00166	0.0022	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00165	0.00219	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00165	0.00218	CbGpPWpGaD
Metixene—Promethazine—DRD2—Gilles de la Tourette syndrome	0.00162	0.0211	CrCbGaD
Metixene—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00161	0.00214	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00158	0.0021	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00157	0.00209	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00208	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00156	0.00207	CbGpPWpGaD
Metixene—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.00155	0.0202	CrCbGaD
Metixene—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.00155	0.0201	CrCbGaD
Metixene—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00154	0.00205	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00153	0.00203	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00153	0.00203	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00151	0.00201	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00151	0.002	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00151	0.002	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00148	0.00197	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00143	0.0019	CbGpPWpGaD
Metixene—Promazine—DRD2—Gilles de la Tourette syndrome	0.00143	0.0185	CrCbGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00142	0.00189	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00142	0.00189	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00141	0.00187	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00139	0.00185	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00179	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00135	0.00179	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00179	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00179	CbGpPWpGaD
Metixene—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.00133	0.0173	CrCbGaD
Metixene—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00126	0.00167	CbGpPWpGaD
Metixene—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.00125	0.0163	CrCbGaD
Metixene—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0012	0.0016	CbGpPWpGaD
Metixene—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.0012	0.0156	CrCbGaD
Metixene—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0012	0.00159	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00119	0.00158	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00117	0.00155	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00117	0.00155	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00116	0.00154	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00116	0.00154	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00116	0.00154	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00153	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00115	0.00153	CbGpPWpGaD
Metixene—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00115	0.00153	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00113	0.0015	CbGpPWpGaD
Metixene—Promazine—HTR2A—Gilles de la Tourette syndrome	0.0011	0.0143	CrCbGaD
Metixene—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00109	0.00144	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00108	0.00144	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00144	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00107	0.00142	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00101	0.00134	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.001	0.00133	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000997	0.00132	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000987	0.00131	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000978	0.0013	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000965	0.00128	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000937	0.00124	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000915	0.00121	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000911	0.00121	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000888	0.00118	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000882	0.00117	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000876	0.00116	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000873	0.00116	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000851	0.00113	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000827	0.0011	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000792	0.00105	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000787	0.00104	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000764	0.00101	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000761	0.00101	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000759	0.00101	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000752	0.000998	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000714	0.000948	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000711	0.000944	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000693	0.000921	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000679	0.000902	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000677	0.000899	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000671	0.00089	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00066	0.000876	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000657	0.000873	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000651	0.000864	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000646	0.000858	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000638	0.000847	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000617	0.000819	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000615	0.000816	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000614	0.000816	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000612	0.000813	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000611	0.000811	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000609	0.000809	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000607	0.000805	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000599	0.000795	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000597	0.000793	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000591	0.000785	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00058	0.000769	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000558	0.000741	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000556	0.000738	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000555	0.000737	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000551	0.000731	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000541	0.000718	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000525	0.000697	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000518	0.000687	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000503	0.000667	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000498	0.000661	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000489	0.000649	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000468	0.000621	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000452	0.000601	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00043	0.000571	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000429	0.00057	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000425	0.000564	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000422	0.00056	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00041	0.000544	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000391	0.000519	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00039	0.000517	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000386	0.000512	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000382	0.000507	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000364	0.000484	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000363	0.000482	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00036	0.000478	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000354	0.00047	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000353	0.000468	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000349	0.000464	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000342	0.000455	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00033	0.000438	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000329	0.000436	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000328	0.000435	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000325	0.000432	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000267	0.000355	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000231	0.000306	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00023	0.000306	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000228	0.000303	CbGpPWpGaD
